6533b872fe1ef96bd12d40be
RESEARCH PRODUCT
Cytomegalovirus DNAemia in patients with de novo acute myeloid leukemia undergoing cytotoxic chemotherapy
Paula AmatCarlos SolanoDavid NavarroEliseo AlbertEstela GiménezAlberto TalayaBlanca NavarroIvan MartinMar TormoMarisa Calabuigsubject
Cancer Researchbusiness.industrymedicine.medical_treatmentIncidence (epidemiology)De novo acuteCongenital cytomegalovirus infectionvirus diseasesMyeloid leukemiaHematologyHematopoietic stem cell transplantationCytotoxic chemotherapymedicine.disease03 medical and health sciencessurgical procedures operative0302 clinical medicineOncology030220 oncology & carcinogenesisCancer researchMedicineIn patientbusiness030215 immunologydescription
There is evidence suggesting that cytomegalovirus (CMV) reactivation following allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be associated with a lower relapse incidence in acu...
year | journal | country | edition | language |
---|---|---|---|---|
2019-05-21 | Leukemia & Lymphoma |